Demcizumab (Anti-DLL4)
A2520
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameDemcizumab (Anti-DLL4)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionDemcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203